Sujin Kang

Dr. Sujin Kang

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
SKSujin Kang
Sujin Kang
SASamantha M Arsenault
Samantha M Arsenault
RORobert C O’brien
Robert C O’brien
MCMarina S Chatzea
Marina S Chatzea
SZSiamak Zarei-Ghanavati
Siamak Zarei-Ghanavati
SYSonia H. Yoo
Sonia H. Yoo
Purpose: This study compared the visual performance, patient-reported outcomes, and spectacle independence of two advanced trifocal intraocular lens (IOL) platforms, Clareon PanOptix and TECNIS Odyssey, in a paired-eye design. The primary hypothesis was that differences in optical design would yield distinct strengths in distance, intermediate, and near visual acuity (VA), contrast sensitivity (CS), and patient satisfaction. Patients and Methods: In this prospective, single-center, single-surgeon trial at the Bascom Palmer Eye Institute, 19 patients (38 eyes; mean age 66.37 ± 10.61 years) undergoing bilateral cataract surgery were stratified by ocular dominance and randomized for dominant-eye IOL allocation. Each patient received a PanOptix (toric or non-toric) in one eye and an Odyssey (toric or non-toric) in the fellow eye, implanted one week apart. Postoperative assessments (≥ 1 month) included monocular distance-corrected VA at distance (CDVA, 4 m), intermediate (DCIVA, 60 cm), and near (DCNVA, 40 cm), uncorrected VAs, residual refraction, CS, and patient-reported visual quality and spectacle independence. Results: Compared with PanOptix, Odyssey achieved significantly better CDVA (EMD=0.03 logMAR, 95% CI [0.01, 0.06], P=0.009) and UCDVA (EMD=0.06 logMAR, 95% CI [0.01, 0.12], P=0.03), while PanOptix demonstrated superior DCIVA (EMD=− 0.05 logMAR, 95% CI [− 0.09, − 0.01], P=0.03). DCNVA, UCIVA, and UCNVA did not differ significantly (P≥ 0.07). CS was higher in Odyssey eyes (EMD=− 5.47, 95% CI [− 10.50, − 0.42], P=0.03). Residual spherical equivalent was similar between groups (− 0.10 D vs − 0.09 D, P=0.91). Rates of starburst, halo, and glare were not significantly different (P≥ 0.34). Spectacle independence was achieved by 17 of 19 patients (89.47%) in both groups. Conclusion: In a paired-eye comparison, PanOptix provided superior intermediate VA, while Odyssey delivered better distance VA and CS. Both lenses yielded high spectacle independence and comparable rates of photic phenomena, supporting their viability as presbyopia-correcting options in cataract surgery.

13 November 2025 in Survey of Ophthalmology
Verified
Journal Article
Open access
SKSujin Kang
Sujin Kang
JHJerry Hsu
Jerry Hsu
SYSonia H. Yoo
Sonia H. Yoo
Cataracts and presbyopia represent leading global causes of visual impairment, and demand for spectacle independence after cataract surgery continues to rise. Pseudophakic mini-monovision, a refined adaptation of traditional monovision employing milder anisometropia (-0.75 to -1.50 diopter), has emerged as an effective and versatile strategy to address this need. Compared with conventional monovision, mini-monovision better preserves stereopsis and binocular vision while providing satisfaction and spectacle independence approaching that of multifocal intraocular lenses (IOLs). Success is influenced by factors such as neuroadaptive capacity, ocular dominance, pupil size, and precision of refractive targeting. Advances in IOL technologies, including enhanced monofocal, extended depth of focus, and light-adjustable lenses, have further expanded mini-monovision's applicability, offering customizable visual outcomes. Careful preoperative evaluation and accurate biometry remain critical to screening candidates and optimizing refractive accuracy. Alternative designs, including crossed and hybrid monovision, extend its clinical versatility. By integrating with modern IOL innovations, mini-monovision provides a cost-conscious, patient-centered approach that balances spectacle independence with visual quality, reinforcing its relevance in personalized refractive cataract surgery.

10 February 2026 in American Journal of Ophthalmology
Verified
Journal Article
Open access
SKSujin Kang
Sujin Kang
TAThomas A. Albini
Thomas A. Albini
NYNicolas A. Yannuzzi
Nicolas A. Yannuzzi
SYSonia H. Yoo
Sonia H. Yoo
DMDarlene Miller
Darlene Miller
HFHarry W Flynn
Harry W Flynn
To characterize the clinical features, risk factors, treatment modalities, and visual outcomes of culture-proven Candida endophthalmitis at a tertiary referral center. Retrospective, single-center, consecutive case series. Forty-six eyes of 46 patients with culture-proven Candida endophthalmitis treated between October 1, 2014, and October 1, 2025. Diagnosis was confirmed by positive intraocular (aqueous or vitreous sample) cultures. Clinical records were reviewed for demographics, comorbidities, risk factors, infection type, treatment course, and visual outcomes. Candida species distribution, clinical presentation, associated risk factors, treatment modalities, complications, and visual acuity (VA) at last follow-up. C. albicans was the most common isolate (32/46, 69.6%), predominating in endogenous cases (92.3%), while non-albicans Candida species were frequent in exogenous infections (C. tropicalis 5/20, 25.0%; C. parapsilosis 4/20, 20.0%; C. glabrata 3/20, 5.0%; P < .001). Endogenous cases were associated with recent hospitalization (8/26, 30.8%), intravenous drug use (IVDU, 8/26, 30.8%), and malignancy (6/26, 23.1%), whereas exogenous infections were related to recent ocular procedure or surgery (16/20, 80.0%) or recent external ocular infection (4/20, 20.0%). Pars plana vitrectomy (PPV) was performed in 25/26 (96.1%) of endogenous and 13/20 (65.0%) of exogenous cases (P = .014). Among intravitreally injected eyes, voriconazole was the most commonly used antifungal agent (35/38, 92.1%). Among systemically treated eyes, fluconazole was the most frequently used antifungal agent (19/37, 51.4%). The most common complication was retinal detachment in both groups (9/46, 19.6%). At last follow-up, VA was significantly better in endogenous than exogenous infection (0.5 LogMAR [∼20/63] vs. 2.3 LogMAR [∼20/3990]; P = .005). Enucleation/evisceration was performed in 1/26 (3.8%) of endogenous cases and 3/20 (15.0%) of exogenous cases. Candida endophthalmitis demonstrates distinct clinical profiles and visual outcomes based on infection source. Endogenous cases, most commonly due to C. albicans, are associated with systemic comorbidities and show comparatively better visual outcomes. Exogenous cases, frequently caused by non-albicans Candida species, are more refractory despite prompt antifungal therapy, vitrectomy, and anterior segment surgeries, often resulting poor visual outcomes.

3 March 2026 in American Journal of Ophthalmology
Verified
Journal Article
Open access
SKSujin Kang
Sujin Kang
JHJerry Hsu
Jerry Hsu
EKEllen H. Koo
Ellen H. Koo
KDKendall E. Donaldson
Kendall E. Donaldson
WCWilliam W. Culbertson
William W. Culbertson
SYSonia H. Yoo
Sonia H. Yoo
To characterize patient-surgeon sex concordance and evaluate sex-based trends in cataract surgical volume over a 14-year period. Retrospective cohort and trend study. All cataract surgeries performed and all surgeons performing cataract surgery at the Bascom Palmer Eye Institute between January 1, 2011, and November 7, 2024. Cataract surgery counts were aggregated by surgeon sex, patient sex, and calendar year to assess patient-surgeon sex concordance and longitudinal trends in surgical volume. Surgeon workforce composition and annual surgical productivity were evaluated using procedure counts. Associations between surgeon sex, sex distribution of operated eyes, and changes in surgical volume over time were examined. Primary outcomes were patient-surgeon sex concordance at the cataract surgery level and surgeon-level cataract surgery volume. Secondary outcomes included temporal trends in surgeon workforce composition and sex-stratified distributions of cataract surgeries. Among 88,420 cataract surgeries (mean age of 68.2 ± 11.1 years; 55.9% female patients; 122 surgeons), women comprised approximately one-third of active surgeons, a proportion that remained stable over time. Patient-surgeon sex concordance was modest (OR, 1.06; 95% CI, 1.03-1.09), indicating limited deviation from equal odds of same-sex pairing. Despite stable workforce representation, female surgeons' share of institutional cataract volume increased from 37.8% in 2011 to 52.8% in 2024 (β = 10.8 cases/year; P < .001), with higher mean annual productivity per surgeon in 2023-2024 compared with male surgeons (249.2 vs 122.7 cases; P = .03). Female surgeon productivity was strongly correlated with patient-surgeon sex concordance over time (ρ=0.83; P < .001). In this large longitudinal cohort, patient-surgeon sex concordance was modest and closely aligned with changes in surgeon productivity and workforce output. These findings suggest that sex-based productivity disparities are modifiable and that institutional factors related to surgical volume distribution may influence gender equity in ophthalmic surgical practice.

21 April 2026 in American Journal of Ophthalmology
Verified
Journal Article
Open access
SKSujin Kang
Sujin Kang
LPLomas S. Persad
Lomas S. Persad
FWFasika A. Woreta
Fasika A. Woreta
SYSonia H. Yoo
Sonia H. Yoo
To compare the incidence and timing of postoperative complications between laser-assisted in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) within a national clinical registry. Retrospective registry-based clinical cohort study. 48,892 eyes of 27,372 patients who underwent refractive surgery in the IRIS® Registry (Intelligent Research in Sight). LASIK and PRK procedures were identified using Healthcare Common Procedure Coding System codes. Postoperative complications, including dry eye disease (DED), visual disturbances, and ocular pain, were identified using International Classification of Diseases codes and analyzed at the eye level. Incidence was evaluated across three postoperative intervals (1 day to 1 month, 1 to 3 months, and 3 to 12 months). Interval-specific incidence rates and incidence rate ratios (IRRs) comparing LASIK and PRK were estimated using multivariable-adjusted Poisson generalized estimating equations. Interval-specific incidence of postoperative complications and comparative IRRs between LASIK and PRK. DED was the most frequently documented postoperative complication, occurring in 16.1% of LASIK eyes and 15.6% of PRK eyes over the follow-up period. During the 1 to 3 months interval, LASIK was associated with a lower incidence of DED compared with PRK (IRR, 0.8 [95% confidence interval (CI), 0.7-0.9]). In the first postoperative month, visual disturbances occurred more frequently after PRK (IRR, 0.3 [95% CI, 0.3-0.4]), but differences between procedures were not significant at later intervals. Ocular pain was rare after both procedures, with no consistent differences in early intervals, but showed a lower incidence after LASIK in the 3 to 12 months interval (IRR, 0.5 [95% CI, 0.3-0.9]). Postoperative complication profiles following refractive surgery varied by procedure and postoperative interval. PRK was associated with a higher risk of visual disturbances in the early postoperative period and a higher incidence of DED during the 1 to 3 months interval compared with LASIK. Ocular pain was rare overall but showed a lower incidence after LASIK in the 3 to 12 months interval, whereas most other complication rates were comparable between procedures. Recognition of these temporal patterns may help guide patient counseling, optimize postoperative follow-up strategies, and guide postoperative management during different phases of corneal recovery after refractive surgery.

Verified
Journal Article
Open access
PDF file
SKSujin Kang
Sujin Kang
BLByron L. Lam
Byron L. Lam
WLWinston Lee
Winston Lee
ABAudina Berrocal
Audina Berrocal
NGNinel Z. Gregori
Ninel Z. Gregori
JSJesse D. Sengillo
Jesse D. Sengillo
Inherited retinal diseases (IRDs) are a major cause of visual impairment worldwide, marked by extensive genetic and phenotypic heterogeneity. Recent estimates from the U.S. suggest a prevalence of nearly 1 in 1000 individuals, reflecting both disease burden and improved diagnostic recognition. This review traces the shift from linkage analysis and Sanger sequencing to high-throughput next-generation sequencing, including panel-based, whole-exome, and whole-genome sequencing. Phenotype-driven testing strategies and standardized variant interpretation frameworks, such as the American College of Medical Genetics and Genomics guidelines, have substantially increased diagnostic yield. Copy number and structural variant detection, transcriptomics, and functional assays further help address unresolved cases. Nonetheless, barriers remain regarding cost, access, and the interpretation of variants of uncertain significance. Molecular confirmation has become essential for access to novel gene-directed therapies, exemplified by voretigene neparvovec for biallelic RPE65 variants, and is often a prerequisite for clinical trial participation. The growing role of genetic testing highlights the need for multidisciplinary evaluation and standardized outcome measures. Emerging tools, including artificial intelligence-assisted variant prioritization, image-to-genotype modeling, and multi-omics analyses, bridge molecular diagnoses with clinical phenotypes, accelerating the transition to targeted therapies. Continued progress will depend on increased access, standardized analytical regulations, and the integration of emerging technologies into routine clinical care.